Request Deal Involvement
Evolent Health completed the acquisition of Magellan Specialty Health from Centene for $800m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
JP Morgan
legal advisors
Skadden Arps Slate Meagher & Flom
legal advisors
King & Spalding
financial advisors
Goldman Sachs
legal advisors
Bass Berry & Sims
or
Principals
target
MAGELLAN SPECIALTY HEALTH
vendor
CENTENE CORPORATION
bidder
EVOLENT HEALTH INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite